Product
Influenza Virus Quadrivalent Inactivated Vaccine
2 clinical trials
2 indications
Indication
InfluenzaIndication
Influenza ImmunizationClinical trial
A Phase 1, Open-Label, Comparator-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Single Dose of VRC H1ssF-3928 mRNA-LNP in Healthy AdultsStatus: Recruiting, Estimated PCD: 2025-08-20
Clinical trial
A Phase I Study to Assess the Safety, Reactogenicity and Immunogenicity of Two Quadrivalent Seasonal Influenza Vaccines (Fluzone(R) or Flublok(R)) With or Without One of Two Adjuvants (AF03 or Advax-CpG55.2) in Healthy Adults 18-45 Years of AgeStatus: Completed, Estimated PCD: 2020-09-18